Literature DB >> 19717021

D-dimer, magnetic resonance imaging diffusion-weighted imaging, and ABCD2 score for transient ischemic attack risk stratification.

Brett L Cucchiara1, Steve R Messe, Lauren Sansing, Larami MacKenzie, Robert A Taylor, James Pacelli, Qaisar Shah, Eleanor S Pollak, Scott E Kasner.   

Abstract

BACKGROUND: We sought to determine whether measurement of D-dimer (DD) would improve risk stratification after transient ischemic attack (TIA).
METHODS: We enrolled 167 patients with acute TIA in a prospective observational study. DD was measured using rapid enzyme-linked immunosorbent assay. The primary outcome measure was a composite end point consisting of stroke or death within 90 days or the identification of a high-risk stroke mechanism requiring specific early intervention (defined as > or =50% stenosis in a vessel referable to symptoms or a cardioembolic source warranting anticoagulation).
RESULTS: The composite end point occurred in 41 patients (25%). A 50% or greater stenosis was found in 25 patients (15%), a cardioembolic source in 14 (8%), and clinical events in 8 (5 strokes, 3 deaths), 6 of whom also had a high-risk cause of TIA. ABCD(2) score was associated with outcome (P for trend = .017, c-statistic 0.63). DD levels did not differ based on outcome status (geometric mean 0.75 v 0.82 microg fibrinogen equivalent unit/mL, P = .56), and DD had little use for predicting outcome (c-statistic 0.57), even when combined with ABCD(2) score. Of 96 patients with early magnetic resonance imaging (MRI), 23% had diffusion-weighted imaging (DWI) abnormalities, and MRI DWI was predictive of outcome (c-statistic 0.76). The addition of MRI DWI to ABCD(2) improved predictive accuracy (c-statistic 0.83) compared with either alone.
CONCLUSIONS: Many patients with TIA have a high-risk mechanism (large vessel stenosis or cardioembolism) or will experience stroke/death within 90 days. Increasing ABCD(2) scores were associated with this composite end point. Measurement of DD did not provide additional prognostic information.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19717021     DOI: 10.1016/j.jstrokecerebrovasdis.2009.01.006

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  7 in total

Review 1.  Early stroke risk and ABCD2 score performance in tissue- vs time-defined TIA: a multicenter study.

Authors:  M F Giles; G W Albers; P Amarenco; E M Arsava; A W Asimos; H Ay; D Calvet; S B Coutts; B L Cucchiara; A M Demchuk; S C Johnston; P J Kelly; A S Kim; J Labreuche; P C Lavallee; J-L Mas; A Merwick; J M Olivot; F Purroy; W D Rosamond; R Sciolla; P M Rothwell
Journal:  Neurology       Date:  2011-08-24       Impact factor: 9.910

Review 2.  ABCD2 score and secondary stroke prevention: meta-analysis and effect per 1,000 patients triaged.

Authors:  Joanna M Wardlaw; Miriam Brazzelli; Francesca M Chappell; Hector Miranda; Kirsten Shuler; Peter A G Sandercock; Martin S Dennis
Journal:  Neurology       Date:  2015-07-01       Impact factor: 9.910

3.  The ABCD and ABCD2 Scores and the Risk of Stroke following a TIA: A Narrative Review.

Authors:  Archit Bhatt; Vishal Jani
Journal:  ISRN Neurol       Date:  2011-07-21

4.  Prediction of recurrent stroke with ABCD2 and ABCD3 scores in patients with symptomatic 50-99% carotid stenosis.

Authors:  Elias Johansson; Jakob Bjellerup; Per Wester
Journal:  BMC Neurol       Date:  2014-11-30       Impact factor: 2.474

5.  Risk of Subsequent Stroke Among Patients Receiving Outpatient vs Inpatient Care for Transient Ischemic Attack: A Systematic Review and Meta-analysis.

Authors:  Shima Shahjouei; Jiang Li; Eric Koza; Vida Abedi; Alireza Vafaei Sadr; Qiushi Chen; Ashkan Mowla; Paul Griffin; Annemarei Ranta; Ramin Zand
Journal:  JAMA Netw Open       Date:  2022-01-04

6.  Anti-Phosphatidylserine-Prothrombin Antibodies are Associated with Outcome in a TIA Cohort.

Authors:  Michael T Mullen; Steven R Messé; Scott E Kasner; Lauren Sansing; M R Husain; Gary L Norman; Zakera Shums; Brett L Cucchiara
Journal:  Front Neurol       Date:  2012-09-28       Impact factor: 4.003

Review 7.  Clinical Risk Score for Predicting Recurrence Following a Cerebral Ischemic Event.

Authors:  Durgesh Chaudhary; Vida Abedi; Jiang Li; Clemens M Schirmer; Christoph J Griessenauer; Ramin Zand
Journal:  Front Neurol       Date:  2019-11-12       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.